Thymus and activation-regulated chemokine (TARC/CCL17) predicts decline of pulmonary function in patients with chronic obstructive pulmonary disease

Thymus and activation-regulated chemokine (TARC/CCL17) predicts decline of pulmonary function in patients with chronic obstructive pulmonary disease

Background: The deterioration of pulmonary function, such as FEV1-decline, is strongly associated with poor prognosis in patients with chronic obstructive pulmonary disease (COPD). However, few investigations shed light on useful biomarkers for predicting the decline of pulmonary function. We evalua...

Full description

Bibliographic Details
Main Authors: Hiroyoshi Machida, Sumito Inoue, Yoko Shibata, Tomomi Kimura, Kento Sato, Koya Abe, Hiroaki Murano, Sujeong Yang, Hiroshi Nakano, Masamichi Sato, Takako Nemoto, Chisa Sato, Michiko Nishiwaki, Keiko Yamauchi, Akira Igarashi, Yoshikane Tokairin, Masafumi Watanabe
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Allergology International
Subjects:
Biomarker
Chronic obstructive pulmonary disease (COPD)
Forxed expiratory volume in one second (FEV1)
Pulmonary function
Thymus and activation-regulated chemokine (TARC/CCL17)
Online Access:http://www.sciencedirect.com/science/article/pii/S132389302030054X

Internet

http://www.sciencedirect.com/science/article/pii/S132389302030054X

Similar Items